Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis

被引:0
|
作者
Cork, M. J. [1 ]
Eichenfield, L. F. [2 ,3 ]
Blauvelt, A. [4 ]
Rosmarin, D. [5 ]
Hussain, I. [6 ]
Davis, J. D. [7 ]
Li, M. [8 ]
Zhang, Q. [7 ]
Gadkari, A. [7 ]
Eckert, L. [9 ]
Kamal, M. A. [7 ]
Bansal, A. [7 ]
机构
[1] Univ Sheffield, Sheffield, S Yorkshire, England
[2] Rady Childrens Hosp, San Diego, CA USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Oregon Med Res Ctr, Portland, OR USA
[5] Tufts Med Ctr, Boston, MA USA
[6] Vital Prospects Clin Res Inst, Tulsa, OK USA
[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[8] Sanofi, Bridgewater, NJ USA
[9] Sanofi, Chilly Mazarin, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
605
引用
收藏
页码:S104 / S104
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    [J]. ALLERGY, 2024, 79 (01) : 174 - 183
  • [22] Dupilumab treatment restores skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Goleva, E.
    Bissonnette, R.
    Berdyshev, E.
    Jurvilliers, P.
    Agueusop, I.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A.
    Zhang, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [23] Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients
    Dal Bello, Giacomo
    Maurelli, Martina
    Schena, Donatella
    Girolomoni, Giampiero
    Gisondi, Paolo
    [J]. DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [24] Dupilumab Treatment Rapidly Improves Itch in Patients With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Chao, Jingdong
    Eckert, Laurent
    Chen, Zhen
    Ardeleanu, Marius
    Shumel, Brad
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Gadkari, Abhijit
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 29 - 29
  • [25] Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis
    Hamilton, Jennifer D.
    Suarez-Farinas, Mayte
    Dhingra, Nikhil
    Cardinale, Irma
    Li, Xuan
    Kostic, Ana
    Ming, Jeffrey E.
    Radin, Allen R.
    Krueger, James G.
    Graham, Neil
    Yancopoulos, George D.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (06) : 1293 - 1300
  • [26] DUPILUMAB TREATMENT RAPIDLY IMPROVES ITCH IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Silverberg, J.
    Chao, J.
    Eckert, L.
    Chen, Z.
    Ardeleanu, M.
    Shumel, B.
    Plaum, S.
    Graham, N.
    Pirozzi, G.
    Gadkari, A.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S95 - S95
  • [27] Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis
    Marcant, P.
    Balaye, P.
    Merhi, R.
    Jendoubi, F.
    Nosbaum, A.
    Raison-Peyron, N.
    Du-Thanh, A.
    Lasek, A.
    Ferrier le Bouedec, M. -C.
    Tetart, F.
    Valois, A.
    Barbarot, S.
    Soria, A.
    Jachiet, M.
    Staumont-Salle, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (06) : E394 - E396
  • [28] Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis
    Ferrucci, Silvia
    Casazza, Giovanni
    Zussino, Martina
    Tavecchio, Simona
    Marzano, Angelo V.
    Tedeschi, Micol
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [29] Clinical efficacy and safety of Dupilumab for the treatment of moderate to severe atopic dermatitis in Korea
    Kim, Jongwook
    Kim, Yeona
    Won, Sang-Hyeon
    Bae, Kyung-Nam
    Lee, Jungsoo
    Shin, Kihyuk
    Kim, Hoonsoo
    Ko, Hyunchang
    Kim, Moon-Bum
    Kim, Byungsoo
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB136 - AB136
  • [30] Clinically meaningful responses in moderate-to-severe atopic dermatitis patients treated with Dupilumab
    de Bruin-Weller, M.
    Eckert, L.
    Simpson, E. L.
    Cork, M. J.
    Ardeleanu, M.
    Chen, Z.
    Shumel, B.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Gadkari, A.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 116 - 116